100% Discreet Packaging: No labels, no pharmacy branding on the outer box.
Tafero-EM (Descovy)
01/27
Tafero-EM is a next-generation, bioequivalent generic PrEP medication that combines Tenofovir Alafenamide (25 mg) and Emtricitabine (200 mg) in a highly effective fixed-dose tablet. Manufactured by Hetero Healthcare Ltd., this advanced HIV prevention treatment is the generic version of Descovy®, offering a superior safety profile for bone density and kidney function compared to older TDF-based regimens. Specifically designed for HIV-negative individuals at risk, Tafero-EM provides a potent, smaller-sized, and clinically proven HIV prophylaxis solution that maintains high efficacy with a reduced metabolic impact, ensuring long-term health and maximum protection.
- Secure Payment
- No Returns (Safety)
- EU Shipping only
Data sheet
- Expiry date
- 01/27
- Trademark
- Descovy
- Use
- PrEP
- Active principle
- Emtricitabine / Alafenamide
- Supply Length
- 30 Tablets
- Dosage
- 1 tablet daily
- Presentation
- Film-Coated Tablets